Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Denmark

Marie Skłodowska-Curie Action · Running

SNAREopathies High-throughput screen for disfunctions in GABA-switch in human neuronal models of SNAREopathies

Coordinator
Kobenhavns Universitet, Denmark
Runs
1 November 2026 to 31 October 2028
Status
Running
EU funding
€248k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101274608

What the project is doing

In the project's own words, from its summary on CORDIS.

SNARE proteins are essential for brain cell communication. They enable the release of signaling molecules like neurotransmitters and neuropeptides by facilitating the fusion of storage vesicles with the cell membrane. Mutations in genes coding for SNARE proteins cause a group of neurodevelopmental disorders known as SNAREopathies, which can include symptoms such as seizures, developmental delays, autism, and motor or speech impairments.

SNAREopathies show very high phenotypic diversity even for patients carrying the same mutation, suggesting that other factors—like the patient's genetic background or other developmental processes—may influence the disease phenotype. One critical process in the brain development is the “GABA-switch”, which determine the GABA neurotransmitter’s action on neurons; early in development, GABA excites neurons; later, it becomes inhibitory.

This switch is vital for the brain to form stable and balanced networks, and it depends on precise control of chloride levels inside neurons. Disruption of this switch has been linked to disorders such as epilepsy and autism. My project will use human neurons derived from stem cells carrying patient-specific SNARE variants to study how these variants affect the timing and function of the GABA-switch. I will develop a novel high-throughput, microscopy-based assay that simultaneously measures intracellular chloride concentration and neuronal network activity, allowing precise determination of the timing of the GABA-switch and its relationship to changes in neuronal activity.

The functional analysis will be complemented by molecular profiling to uncover underlying mechanisms of affected molecular pathways in SNAREopathies. Finally, I will use my high-throughput microscopy platform to screen candidate compounds with the potential to restore proper signaling in affected neurons. This project will help to better understand SNAREopathies and lay the groundwork for new therapeutic strategies.

Topics

Who is involved

OrganisationCityCountryRole
Kobenhavns UniversitetKobenhavnDenmarkCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI